IL-1 Alpha Regulates CXCL1, CXCL10 and ICAM1 in Network Form in Oral Keratinocytes

被引:13
|
作者
Wu, Tong [1 ]
Du, Rui [1 ]
Hong, Yun [1 ]
Jia, Lihua [1 ]
Zeng, Qi [1 ]
Cheng, Bin [1 ]
机构
[1] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Oral Med, Guangzhou 510060, Guangdong, Peoples R China
关键词
IL-1; alpha; CXCL1; CXCL10; ICAM1; oral keratinocytes; oral lichen planus; LICHEN-PLANUS; CYTOKINES; MODEL;
D O I
10.7754/Clin.Lab.2012.121029
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Keratinocytes are the major constituent of epithelial cells at skin and mucosal surfaces such as oral mucosa. In our previous study, it was indicated that oral keratinocytes play active roles in oral mucosal adaptive immune response and an IL-alpha sub-network was identified. In the past decades IL-1, a revolutionarily ancient cytokine, has attracted our attention for its important roles in innate and adaptive immune responses. In this study we aim to show the IL-alpha sub-network in oral keratinocytes and explore its relevance in oral lichen planus (OLP). Methods: We first tested whether IL-1 alpha regulated its sub-network genes including CXCL1, CXCL10, and ICAM1 mRNA levels in time and concentration dependent manners by real time PCR. Then we investigated the expression of IL-1 alpha and CXCL1 in OLP tissues by immunohistochemical staining. Results: IL-1 alpha regulated its sub-network genes including CXCL1, CXCL10, and ICAM1 mRNA levels in time dependent but not in concentration dependent manner. Immunohistochemistry studies showed that IL-1 alpha and CXCL1 were expressed in OLP tissues, which were only detected in tissue transudate and whole unstimulated saliva in previous studies. Conclusions: IL-1 alpha regulates CXCL1, CXCL10, and ICAM1 in network form in oral keratinocytes. A complete characterization of the IL-1 alpha sub-network will shed light on the exploration of IL-1 as the therapeutic target in OLP and help to illuminate the multiple regulatory functions of keratinocytes in oral mucosa or even in other mucosa sites.
引用
收藏
页码:1105 / 1111
页数:7
相关论文
共 50 条
  • [41] Chemokine CXCL10 gene polymorphisms are associated with type 1 diabetes
    Ramos-Lopez, E.
    Bartsch, W.
    Brueck, P.
    Kahles, H.
    Penna-Martinez, M.
    Herwig, J.
    Badenhoop, K.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 : S85 - S85
  • [42] CXCL1 (GRO-alpha) chemokine in acute ischaemic stroke patients
    Losy, J
    Zaremba, J
    Skrobanski, P
    FOLIA NEUROPATHOLOGICA, 2005, 43 (02) : 97 - 102
  • [43] Elevated IL-1α and CXCL10 serum levels occur in patients with homozygous sickle cell disease and a history of acute splenic sequestration
    Driss, Adel
    Wilson, Nana O.
    Mason, Karlene
    Hyacinth, Hyacinth I.
    Hibbert, Jacqueline M.
    Serjeant, Graham R.
    Stiles, Jonathan K.
    DISEASE MARKERS, 2012, 32 (05) : 295 - 300
  • [44] CXCL1 Regulates Pulmonary Host Defense to Klebsiella Infection via CXCL2, CXCL5, NF-κB, and MAPKs
    Cai, Shanshan
    Batra, Sanjay
    Lira, Sergio A.
    Kolls, Jay K.
    Jeyaseelan, Samithamby
    JOURNAL OF IMMUNOLOGY, 2010, 185 (10): : 6214 - 6225
  • [45] Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth
    Botton, T.
    Puissant, A.
    Cheli, Y.
    Tomic, T.
    Giuliano, S.
    Fajas, L.
    Deckert, M.
    Ortonne, J-P
    Bertolotto, C.
    Tartare-Deckert, S.
    Ballotti, R.
    Rocchi, S.
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (01): : 109 - 121
  • [46] Significance of serum CXCL10/IP-10 level in type 1 diabetes
    Shigihara, T
    Oikawa, Y
    Kanazawa, Y
    Okubo, Y
    Narumi, S
    Saruta, T
    Shimada, A
    JOURNAL OF AUTOIMMUNITY, 2006, 26 (01) : 66 - 71
  • [47] Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth
    T Botton
    A Puissant
    Y Cheli
    T Tomic
    S Giuliano
    L Fajas
    M Deckert
    J-P Ortonne
    C Bertolotto
    S Tartare-Deckert
    R Ballotti
    S Rocchi
    Cell Death & Differentiation, 2011, 18 : 109 - 121
  • [48] Keratin 17 up-regulates the interleukin-17A-induced expression of CCL3 and CXCL1 in keratinocytes
    Jin Liang
    Dang Er-le
    Sun Zhong-bin
    Hu Lei
    Yang Lu-ting
    Wang Gang
    JOURNAL OF DERMATOLOGY, 2012, 39 : 31 - 31
  • [49] Plasma Levels of CXCL1 (GRO-α) and CXCL10 (IP-10) are Elevated in Type 2 Diabetic Patients: Evidence for the Involvement of Inflammation and Angiogenesis/Angiostasis in this Disease State
    Sajadi, Seyyed Mohamad Ali
    Khoramdelazad, Hossein
    Hassanshahi, Gholamhossein
    Rafatpanah, Houshang
    Hosseini, Javad
    Mahmoodi, Mehdi
    Arababadi, Mohammad Kazemi
    Derakhshan, Reza
    Hasheminasabzavareh, Roshanak
    Hossein-Zijoud, Seyed-Mostafa
    Ahmadi, Zahra
    CLINICAL LABORATORY, 2013, 59 (1-2) : 133 - 137
  • [50] Astrocytes in the degenerating brain are primed to synthesize exaggerated levels of CXCL1 and CCL2 in response to IL-1/TNF-stimulation
    Hennessy, Edel
    Cunningham, Colm
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 : S78 - S78